Szela Mary T 5
5 · TriSalus Life Sciences, Inc. · Filed Jul 1, 2026
Insider Transaction Report
Form 5
Szela Mary T
DirectorCEO and President
Transactions
- Award
Common Stock
[F1]2024-12-31$4.26/sh+3,530$15,038→ 513,207 total - Award
Common Stock
[F1]2025-06-30$4.23/sh+2,848$12,047→ 596,726 total - Award
Common Stock
[F1]2025-12-31$4.38/sh+2,100$9,198→ 1,023,826 total
Footnotes (1)
- [F1]Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Signature
/s/ Mary Szela|2026-07-01